Candies
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Cancer Therapies Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immunological and Vaccine Approaches
1.2.3 Antiproliferative Approaches
1.2.4 Photodynamic Therapy
1.2.5 Gene Therapy Approaches
1.2.6 Cell Cycle and Apoptosis Approaches
1.3 Market by Application
1.3.1 Global Cancer Therapies Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapies Market Perspective (2017-2028)
2.2 Cancer Therapies Growth Trends by Region
2.2.1 Cancer Therapies Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Therapies Historic Market Size by Region (2017-2022)
2.2.3 Cancer Therapies Forecasted Market Size by Region (2023-2028)
2.3 Cancer Therapies Market Dynamics
2.3.1 Cancer Therapies Industry Trends
2.3.2 Cancer Therapies Market Drivers
2.3.3 Cancer Therapies Market Challenges
2.3.4 Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapies Players by Revenue
3.1.1 Global Top Cancer Therapies Players by Revenue (2017-2022)
3.1.2 Global Cancer Therapies Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapies Revenue
3.4 Global Cancer Therapies Market Concentration Ratio
3.4.1 Global Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapies Revenue in 2021
3.5 Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Cancer Therapies Product Solution and Service
3.7 Date of Enter into Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapies Breakdown Data by Type
4.1 Global Cancer Therapies Historic Market Size by Type (2017-2022)
4.2 Global Cancer Therapies Forecasted Market Size by Type (2023-2028)
5 Cancer Therapies Breakdown Data by Application
5.1 Global Cancer Therapies Historic Market Size by Application (2017-2022)
5.2 Global Cancer Therapies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Therapies Market Size (2017-2028)
6.2 North America Cancer Therapies Market Size by Country (2017-2022)
6.3 North America Cancer Therapies Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Therapies Market Size (2017-2028)
7.2 Europe Cancer Therapies Market Size by Country (2017-2022)
7.3 Europe Cancer Therapies Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapies Market Size (2017-2028)
8.2 Asia-Pacific Cancer Therapies Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Therapies Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Therapies Market Size (2017-2028)
9.2 Latin America Cancer Therapies Market Size by Country (2017-2022)
9.3 Latin America Cancer Therapies Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapies Market Size (2017-2028)
10.2 Middle East & Africa Cancer Therapies Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Therapies Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Therapies Introduction
11.1.4 Amgen Revenue in Cancer Therapies Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Therapies Introduction
11.2.4 AstraZeneca Revenue in Cancer Therapies Business (2017-2022)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Cancer Therapies Introduction
11.3.4 Bristol-Myers Squibb Revenue in Cancer Therapies Business (2017-2022)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Cancer Therapies Introduction
11.4.4 Bayer AG Revenue in Cancer Therapies Business (2017-2022)
11.4.5 Bayer AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 GlaxoSmithKline PLC
11.6.1 GlaxoSmithKline PLC Company Detail
11.6.2 GlaxoSmithKline PLC Business Overview
11.6.3 GlaxoSmithKline PLC Cancer Therapies Introduction
11.6.4 GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2017-2022)
11.6.5 GlaxoSmithKline PLC Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cancer Therapies Introduction
11.7.4 Johnson & Johnson Revenue in Cancer Therapies Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Company Detail
11.8.2 Merck & Co. Inc. Business Overview
11.8.3 Merck & Co. Inc. Cancer Therapies Introduction
11.8.4 Merck & Co. Inc. Revenue in Cancer Therapies Business (2017-2022)
11.8.5 Merck & Co. Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Detail
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Cancer Therapies Introduction
11.9.4 Novartis AG Revenue in Cancer Therapies Business (2017-2022)
11.9.5 Novartis AG Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Detail
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Cancer Therapies Introduction
11.10.4 Pfizer Inc. Revenue in Cancer Therapies Business (2017-2022)
11.10.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Therapies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunological and Vaccine Approaches
Table 3. Key Players of Antiproliferative Approaches
Table 4. Key Players of Photodynamic Therapy
Table 5. Key Players of Gene Therapy Approaches
Table 6. Key Players of Cell Cycle and Apoptosis Approaches
Table 7. Global Cancer Therapies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Cancer Therapies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Cancer Therapies Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Cancer Therapies Market Share by Region (2017-2022)
Table 11. Global Cancer Therapies Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Cancer Therapies Market Share by Region (2023-2028)
Table 13. Cancer Therapies Market Trends
Table 14. Cancer Therapies Market Drivers
Table 15. Cancer Therapies Market Challenges
Table 16. Cancer Therapies Market Restraints
Table 17. Global Cancer Therapies Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Cancer Therapies Market Share by Players (2017-2022)
Table 19. Global Top Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapies as of 2021)
Table 20. Ranking of Global Top Cancer Therapies Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Cancer Therapies Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Therapies Product Solution and Service
Table 24. Date of Enter into Cancer Therapies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Therapies Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Cancer Therapies Revenue Market Share by Type (2017-2022)
Table 28. Global Cancer Therapies Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Cancer Therapies Revenue Market Share by Type (2023-2028)
Table 30. Global Cancer Therapies Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Cancer Therapies Revenue Market Share by Application (2017-2022)
Table 32. Global Cancer Therapies Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Cancer Therapies Revenue Market Share by Application (2023-2028)
Table 34. North America Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Cancer Therapies Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Cancer Therapies Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Cancer Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Cancer Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 44. Amgen Company Detail
Table 45. Amgen Business Overview
Table 46. Amgen Cancer Therapies Product
Table 47. Amgen Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 48. Amgen Recent Development
Table 49. AstraZeneca Company Detail
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Cancer Therapies Product
Table 52. AstraZeneca Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. Bristol-Myers Squibb Company Detail
Table 55. Bristol-Myers Squibb Business Overview
Table 56. Bristol-Myers Squibb Cancer Therapies Product
Table 57. Bristol-Myers Squibb Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 58. Bristol-Myers Squibb Recent Development
Table 59. Bayer AG Company Detail
Table 60. Bayer AG Business Overview
Table 61. Bayer AG Cancer Therapies Product
Table 62. Bayer AG Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 63. Bayer AG Recent Development
Table 64. F. Hoffmann-La Roche Ltd Company Detail
Table 65. F. Hoffmann-La Roche Ltd Business Overview
Table 66. F. Hoffmann-La Roche Ltd Cancer Therapies Product
Table 67. F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 68. F. Hoffmann-La Roche Ltd Recent Development
Table 69. GlaxoSmithKline PLC Company Detail
Table 70. GlaxoSmithKline PLC Business Overview
Table 71. GlaxoSmithKline PLC Cancer Therapies Product
Table 72. GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 73. GlaxoSmithKline PLC Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Cancer Therapies Product
Table 77. Johnson & Johnson Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Merck & Co. Inc. Company Detail
Table 80. Merck & Co. Inc. Business Overview
Table 81. Merck & Co. Inc. Cancer Therapies Product
Table 82. Merck & Co. Inc. Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 83. Merck & Co. Inc. Recent Development
Table 84. Novartis AG Company Detail
Table 85. Novartis AG Business Overview
Table 86. Novartis AG Cancer Therapies Product
Table 87. Novartis AG Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. Pfizer Inc. Company Detail
Table 90. Pfizer Inc. Business Overview
Table 91. Pfizer Inc. Cancer Therapies Product
Table 92. Pfizer Inc. Revenue in Cancer Therapies Business (2017-2022) & (US$ Million)
Table 93. Pfizer Inc. Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Therapies Market Share by Type: 2021 VS 2028
Figure 2. Immunological and Vaccine Approaches Features
Figure 3. Antiproliferative Approaches Features
Figure 4. Photodynamic Therapy Features
Figure 5. Gene Therapy Approaches Features
Figure 6. Cell Cycle and Apoptosis Approaches Features
Figure 7. Global Cancer Therapies Market Share by Application in 2021 & 2028
Figure 8. Hospital Use Case Studies
Figure 9. Clinic Use Case Studies
Figure 10. Household Case Studies
Figure 11. Other Case Studies
Figure 12. Cancer Therapies Report Years Considered
Figure 13. Global Cancer Therapies Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Cancer Therapies Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Cancer Therapies Market Share by Region: 2021 VS 2028
Figure 16. Global Cancer Therapies Market Share by Players in 2021
Figure 17. Global Top Cancer Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapies as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Therapies Revenue in 2021
Figure 19. North America Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Cancer Therapies Market Share by Country (2017-2028)
Figure 21. United States Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Cancer Therapies Market Share by Country (2017-2028)
Figure 25. Germany Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Cancer Therapies Market Share by Region (2017-2028)
Figure 33. China Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Cancer Therapies Market Share by Country (2017-2028)
Figure 41. Mexico Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Cancer Therapies Market Share by Country (2017-2028)
Figure 45. Turkey Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Cancer Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Amgen Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 48. AstraZeneca Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 50. Bayer AG Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 51. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 52. GlaxoSmithKline PLC Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 53. Johnson & Johnson Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 54. Merck & Co. Inc. Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 55. Novartis AG Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 56. Pfizer Inc. Revenue Growth Rate in Cancer Therapies Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen AstraZeneca Bristol-Myers Squibb Bayer AG F. Hoffmann-La Roche Ltd GlaxoSmithKline PLC Johnson & Johnson Merck & Co. Inc. Novartis AG Pfizer Inc.